OmniaBio
OmniaBio

OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.
omniabio.com
Hamilton, ON, Canada
Inaccurate data? Flag it here.
Open jobs at OmniaBio